Delaware
|
001-14339
|
58-1528626
|
(State of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
o | Written communications pursuant to Rule 425 under the Securities Act. |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
|
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. |
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
1.
|
A proposal to elect two Class I directors to serve for a term expiring in 2014:
|
Class I Director
|
Votes For
|
Votes
Withheld
|
Broker
Non-votes
|
|||||||
John V. Herndon
|
18,058,180 | 564,397 | 8,044,967 | |||||||
Peter A. A. Saunders
|
17,599,315 | 1,023,262 | 8,044,967 |
2.
|
A proposal to ratify the appointment of Dixon Hughes PLLC as the Company’s independent auditor for the year ending December 31, 2011:
|
For
|
Against
|
Abstentions
|
Broker
Non-votes
|
||||||||
26,405,461 | 135,478 | 127,205 | 0 |
THERAGENICS CORPORATION | ||||
(Registrant) | ||||
Dated: May 24, 2011
|
|
By:
|
/s/ M. Christine Jacobs | |
M. Christine Jacobs | ||||
Chief Executive Officer | ||||